read the following information and select the appropriate link
at the bottom of the page to continue.
Audience: Pharmacists, nurses, and dietitians who
are involved with patient education and counseling
To increase awareness of the role of blood glucose
monitoring in the management of diabetes and to provide information
that will improve the prognosis of patients with diabetes
Objectives: Upon completion of this activity participants
should be able to:
the prevalence of diabetes and risk of complications
the history of targeted glucose testing
the benefits of targeted glycemic control
the importance of empowering patients to manage diabetes
and discuss currently marketed glucose monitors and identify
key features of different glucose monitors
the importance of pattern management
The American Association of Diabetes Educators and Novo
Nordisk Pharmaceuticals, Inc. are accredited by the American
Council on Pharmaceutical Education (ACPE) as providers of continuing
pharmaceutical education. This program provides for 1.25 contact
hours (.125 CEUs). ACPE Universal Program Number 069-360-02-871-H04
Nurses: This program for 1.5 contact hours has been
approved by the American Association of Diabetes Educators which
is accredited as an approver of continuing education in nursing
by the American Nurses Credentialing Center's Commission of
Accreditation. Approval of this continuing education activity
does not imply endorsement by AADE. Approval number 0203-013
American Association of Diabetes Educators (AM001) is a
Continuing Professional Education (CPE) Accredited Provider
with the Commission on Dietetic Registration (CDR) from June
1, 2003 to May 31, 2006. Registered dietitians (RD) and dietetic
technicians, registered (DTR) will receive 1.0 Continuing Professional
Education Units (CPEUs) for completion of this program. Continuing
Professional Education Provider Accreditation does not constitute
endorsement by CDR of a provider, program, or materials.
Release Date: 12/03/02
Planned Expiration Date: 12/03/04
receive a statement of credit, you must:
complete the post-test (70% or better).
the program evaluation.
of credit will be issued immediately upon successful completion
of the test and submission of the evaluation form. The statement
of credit specific to your discipline will appear on your screen
and you will be given the option to print it for your files.
No additional statement of credit will be issued.
Meece, R.Ph., F.A.C.A, C.D.E
and Certified Diabetes Educator
Owner and Director of Clinical Services:
Plaza Pharmacy And Wellness Center
following program is a presentation by Jerry Meece. Mr.
Meece is a pharmacist and Certified Diabetes Educator who is
owner and Director of Clinical Services of Plaza Pharmacy And
Wellness Center in Gainesville, Texas. Mr. Meece has written
many articles on diabetes care and insulin use in the patient
with diabetes. He has also spoken across the country on the
subject of diabetes and disease state management in the pharmacy
setting. Mr. Meece currently serves on the Board of Directors
for the American Association of Diabetes Educators and is also
chairman of the Public Affairs Committee for that organization.
There is no fee to receive credits for this program.
Supporter: This program has been supported through
an unrestricted educational grant from Novo Nordisk Pharmaceuticals,
Xtra and Sof-Tact trademarks of Abbott Laboratories.
Precision QID registered trademark of Abbott Laboratories.
Glucometer Elite XL, Glucometer Elite, and Glucometer DEX2 registered
trademarks of Bayer Corporation Diagnostics.
Supreme II, Assure, and Select GT registered trademarks of Hypoguard
One Touch Ultra, One Touch Profile, and One Touch SureStep registered
trademarks of LifeScan, Inc, a Johnson and Johnson company.
In Charge and ExpressView trademarks of LXN Corporation.
Duet registered trademark of LXN Corporation.
Accu-Chek Active, Accu-Chek Advantage, and Accu-Chek Complete
registered trademarks of Roche Diagnostics Corporation.
Prestige IQ and Prestige LX registered trademarks of Home Diagnostics,
FreeStyle registered trademark of TheraSense, Inc.
CheckMate Plus registered trademark of QuestStar Medical.
ReliOn registered trademark of Wal-Mart Stores, Inc.
Induo trademark of Life Scan, Inc., a Johnson & Johnson company.
GlucoWatch Biographer registered trademark of Cygnus, Inc.
is the policy of Novo Nordisk Pharmaceuticals, Inc. and the
American Association of Diabetes Educators to ensure independence,
balance, objectivity, scientific rigor, and integrity in all
of their continuing education activities. The faculty must disclose
to the participants any significant relationships with the commercial
companies whose products or devices may be mentioned in the
activity or with the supporter of this continuing education
activity. The information is for participant information; it
is not assumed that these relationships will have a negative
impact on the content of the activity.
Meece has disclosed that he is a consultant for Eli Lilly and
Company and LifeScan Inc., a Johnson and Johnson company. He
is also on the speaker's bureau for Eli Lilly and Company, LifeScan,
and Novo Nordisk Pharmaceuticals, Inc.
of credit for this continuing education program does not imply
endorsement by AADE of any product or manufacturer identified.
- Any medications
or treatment methods suggested in this CE activity should
not be used by the practitioner without evaluation of their
patient's condition(s) and possible contraindication(s) or
danger(s) of use of any specific medication.
activity may include discussions of products or devices that
are not currently approved for use by the Food and Drug Administration
Nordisk Pharmaceuticals, Inc., the American Association of
Diabetes Educators, and the activity's faculty do not endorse
the use of any product in a manner that is not approved by
author, sponsor, and publisher of this continuing education
program have made all reasonable efforts to ensure that
information contained herein is accurate in accordance with
the latest available scientific knowledge at the time of
accreditation of this continuing education program. Information
regarding drugs (e.g., their administration, dosages, contraindications,
adverse reactions, interactions, special warnings, precautions)
and drug delivery systems is subject to change, however,
and the reader is advised to check the manufacturer's package
insert for information concerning recommended dosage and
potential problems or cautions prior to dispensing or administering
the drug or using the drug delivery systems.
the appropriate profession to continue to the activity:
© 2002 Novo Nordisk Pharmaceuticals, Inc. All rights reserved.
Copyright© 2004 CECity® All rights reserved.